Cargando…
Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
SIMPLE SUMMARY: Tamoxifen, an antiestrogen, is a potent drug to treat and prevent hormone dependent breast cancer. As it has low toxicity and is widely available, tamoxifen has become one of the most frequently prescribed anticancer drugs worldwide. A major side effect of tamoxifen is to increase th...
Autores principales: | Emons, Günter, Mustea, Alexander, Tempfer, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564212/ https://www.ncbi.nlm.nih.gov/pubmed/32906618 http://dx.doi.org/10.3390/cancers12092535 |
Ejemplares similares
-
Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO)
por: Emons, Günter, et al.
Publicado: (2019) -
Statement of the Uterus Committee of the Gynaecological Oncology Working Group (AGO) on the PORTEC-3 study
por: Emons, Günther, et al.
Publicado: (2018) -
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer
por: Emons, Günter, et al.
Publicado: (2021) -
Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management
por: Dörk, Thilo, et al.
Publicado: (2020) -
Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review
por: Tempfer, Clemens B., et al.
Publicado: (2020)